[ET Net News Agency, 10 December 2019] Sino Biopharmaceutical Limited (01177) said
"Ademetionine 1,4-Butanedisulfonate for Injection" (brand name "Baixinuo"), a cholagogue
developed by Chia-Tai Tianqing Pharmaceutical Group Co., Ltd, a subsidiary of the company,
has obtained the approval for drug registration granted by the National Medical Products
Administration of the People's Republic of China. This product is applicable to the
prevention of intrahepatic cholestasis before and during cirrhosis and intrahepatic
cholestasis during pregnancy.
Ademetionine is a physiologically active molecule present in human body, serving as a
methyl donor and precursor of physiological sulphur compounds in various important
biochemical reactions, which are conducive to the prevention of intrahepatic cholestasis.
(RC)